Literature DB >> 6363178

Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.

T Kasperska-Czyźykowa, L G Heding, A Czyzyk.   

Abstract

The levels of proinsulin, immunoreactive insulin, true insulin (calculated from the difference, namely immunoreactive insulin-proinsulin) and C-peptide were determined in the fasting state and during a 3-h oral glucose tolerance test after administration of 100 g of glucose in 12 patients with cirrhosis with normal oral glucose tolerance test (50 g) and in 12 healthy subjects serving as controls. In the patients with cirrhosis the serum levels of proinsulin and immunoreactive insulin were significantly higher in the fasting state and after glucose loading than in the healthy subjects. The serum level of true insulin was also higher in the patients with cirrhosis, but the difference was less pronounced and only significant at a few of the time points. The serum level of C-peptide was very similar in both groups. These results emphasize that cirrhosis is a condition in which the serum proinsulin level is raised and that this hyperproinsulinaemia contributes greatly to the increased immunoreactive insulin levels observed in patients with this disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363178     DOI: 10.1007/bf00284460

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  [Carbohydrate metabolism in liver cirrhosis. II. Insulinemia following loading with glucose alone and in combination with glucagon and tolbutamide].

Authors:  M Smoczyński
Journal:  Pol Arch Med Wewn       Date:  1975-11

2.  Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Authors:  A V Greco; F Crucitti; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi; A Bertoli
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

3.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

4.  Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

Authors:  A V Greco; G Ghirlanda; C Patrono; G Fedili; R Manna
Journal:  Acta Diabetol Lat       Date:  1974 Jul-Aug

5.  The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.

Authors:  T Kasperska; J Lawecki; H Rogala; A Czyzyk
Journal:  Diabetologia       Date:  1971-10       Impact factor: 10.122

6.  [Diminished glucose tolerance and increases insulin response in cirrhosis].

Authors:  J P Felber; P Magnenat; A Vannotti
Journal:  Schweiz Med Wochenschr       Date:  1967-11-18

7.  C-peptide and proinsulin after oral glucose.

Authors:  L G Heding; T Kasperska-Czyzykowa
Journal:  Acta Med Scand Suppl       Date:  1980

8.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

9.  Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.

Authors:  J L Shurberg; R H Resnick; R S Koff; E Ros; R A Baum; J A Pallotta
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  2 in total

1.  Hyperproinsulinaemia in cirrhosis.

Authors:  T Kasperska-Czyzykowa; L G Heding; A Czyzyk
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

2.  Hyperproinsulinaemia in cirrhosis.

Authors:  R Taylor; K G Alberti
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.